Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Virtu Financial Inc. Class A Common Stock (VIRT) vs GeneDx Holdings Corp (WGS) Price & Performance

Virtu Financial Inc. Class A Common StockTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Virtu Financial Inc. Class A Common Stock vs GeneDx Holdings Corp — how do they compare? Virtu Financial Inc. Class A Common Stock trades at $57.56 (market cap $5.19B), while GeneDx Holdings Corp trades at $67.73 (market cap $2.04B). The key difference: Virtu Financial Inc. Class A Common Stock is far larger — about 2.5× GeneDx Holdings Corp's market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Virtu Financial Inc. Class A Common Stock for 0 Days and GeneDx Holdings Corp for 19 Days on average.

VIRTWGS
Market Cap
$5.19B$2.04B
Volume
1,186,043659,215
Sector
FinancialsHealth
52-Week High
$67.93$167.51
52-Week Low
$32.53$34.51
Typical Hold Time
0 Days19 Days
Enterprise Value
$14.90B$2.08B
Dividend Yield
1.63%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Virtu Financial Inc. Class A Common Stock

No Aura AI signal available yet.

GeneDx Holdings Corp

GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.

The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VIRT
100% Buy0% Sell
Avg holding period · 0 Days
WGS
53% Buy47% Sell
Avg holding period · 19 Days

About Virtu Financial Inc. Class A Common Stock

Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.

Read more on VIRT →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →